use is also complicated because of its high fibrinogen content. Fibrinogen is the largest of the plasma protein molecules with a molecular weight of 350,000 and a half-life of five days. As half the AHG disappears from the circulation in twelve hours and half of the associated fibrinogen takes five days it is obvious that the maintenance ofa proper level of AHG results in an ever-increasing concentration of fibrinogen and this may have adverse effects.
One of the most interesting pathological and surgical problems specific to the hlmophilic patient is the so-called 'haemophilic cyst': as a result of perhaps trivial injury bleeding may occur beneath the periosteum of a bone, particularly in the pelvis or leg, and spread very slowly causing pressure necrosis wherever it extends. Patients have been seen in whom the cyst has taken twenty-five years to grow to an immense size, extruding into fascial planes between muscles and perforating bones as in a malignant process. Some thrombus formation takes place within the cyst but oozing of blood continues and many pints of fluid blood may be contained in the various loculi of the cyst. The condition may be diagnosed as a malignant tumour and a needle biopsy performed; this causes external bleeding and introduces infection which leads to death. Sometimes the very pressure of the cyst may cause necrosis of the skin and spontaneous rupture. When the condition occurs in the legs it has in the past inevitably led to amputation and this has been undertaken with success. In recent years, however, the blood coagulation research unit in Oxford under the direction of Professor Macfarlane has made it possible to embark on a programme of excision of these cysts with the aim of saving the limbs. The first successful excision was performed in Oxford on December 4, 1959, for a patient in whom the cyst formed a mass in the buttocks and the top of the thigh, extended through the ileum and sacrosciatic foramen into the true pelvis and formed an enormous mass inside the abdomen in the retroperitoneal space. Every loculus was removed by an operation that took ten hours; no limb or organ had to be sacrificed. The first excision of a cyst in the thigh which resulted in the saving of a leg was performed by Mr A J Gunning in Oxford on August 11, 1962. These operations were carried out with control of the hlmostatic mechanism over many weeks. For this purpose all forms of AHG had to be used in succession as resistance to a particular variety occurred. As already indicated, one of the lessons we have learnt is that immobilization of the limb in a plaster case until healing is complete is important in order to avoid fresh bleeding. Altogether 6 such patients have been treated successfully in Oxford.
These cysts might theoretically occur also in Christmas disease but none has so far been observed. In the performance of routine surgical operations in this condition replacement therapy is satisfactory by a concentrate which in addition to Christmas factor also contains Factors X, VII, and prothrombin. The correct dose must be estimated on the assumption that only 20-50 % of what is given can be recovered in the plasma but, as the half-life of Christmas factor is eighteen to thirty hours, the determinations and injections are not as tedious as in hemophilia.
The surgery of these conditions does not differ from that in patients with normally coagulating blood. Surgery is, after all, a more or less standard technique used in association with a knowledge of normal and abnormal function. The effects of variations in technique between one surgeon and another are small compared with those that arise from differences in their appreciation of function. Our interest in and moderate success with these patients is entirely dependent on the specialized 'know how' of Professor Macfarlane and his team.
Professor Sheila Sherlock and Dr L Alpert (Department ofMedicine, Royal Free Hospital, London) Bleeding in Surgery in Relation to Liver Disease Two main problems must be discussed: (1) Surgery in jaundiced patients. (2) Bleeding in those with known abnormal liver function in whom operations are essential.
The liver must be considered in relation to blood coagulation. This can be considered simply as the factors concerned in the one-stage prothrombin time, the usual routine test performed in hospital laboratories. This measures not only prothrombin but also Factors VII, X, V and fibrinogen. It takes no account ofAHG, Christmas factor (Factor IX), Hagemann factor or platelets; AHG is not synthesized by liver and is irrelevant to the present discussion. Christmas factor (and also platelets) may be deficient in patients with liver disease. Hagemann factor deficiency has not been shown in liver disease. For practical purposes the one-stage prothrombin time is a sufficient indication of an adequate clotting mechanism in jaundiced patients. If doubt arises concerning the others the thromboplastin test of Biggs & Douglas (1953) 
injection is effective in about three hours. The value of vitamin K1 therapy is emphasized by our results. Six of 10 patients with infective hepatitis and 15 of 21 patients with hepatic cirrhosis showed a lessening of prothrombin time of at least 2 seconds after intramuscular vitamin K1 therapy for three days. Patients with obstructive jaundice showed the expected decrease of prothrombin time.
"VIRUS HEPATITIS'
The prothrombin ratio (one-stage prothrombin time in the patient related to the control value) in acute hepatic necrosis with hepatic coma. The hepatotoxic group had received various drugs, the virus hepatitis group had not. Both groups had received parenteral vitamin K1 therapy. Note the extremely high ratio, especially in those who died (Cook & Sherlock 1965) Factors VII, X and IX and also prothrombin require vitamin K for their synthesis by the liver. They are liable to be deficient where bacterial synthesis of the vitamin in the intestine is inadequate, as after wide-spectrum antibiotics: the one-stage prothrombin time may lengthen after long-term neomycin therapy in patients with hepatic encephalopathy. Bile salts are necessary for the adequate absorption of vitamin K from the intestine; diminished quantities of bile salts are found in the intestine in obstructive jaundice and in biliary fistula, and also in hepatocellular disease where there is a failure of the liver cell to secrete adequate amounts of bile salts. A prolonged one-stage prothrombin time in a patient with hepatocellular jaundice may be related not to failure of theliver to synthesize the various factors but to failure of the liver to secrete bile salts. Vitamin K therapy will correct this bile salt secretory failure. It is worth while giving vitamin K to all jaundiced patients with a prolonged onestage prothrombin time. The usual course is 10 mg vitamin K1, the oil-soluble naturally occurring vitamin, by intramuscular injection for five days. Synthetic vitamin K derivative may be used; this is only slightly cheaper than the natural vitamin (10 mg vitamin K1 costs approximately 2s whereas 10 mg of a synthetic preparation costs about 7d). The natural vitamin is speedier and intramuscular When the cause of the prolonged prothrombin time is predominantly hepatocellular disease this will not be completely restored by vitamin K1 treatment. Persistently gross elevation (more than 4 seconds over the control value) of the prothrombin time in a jaundiced patient in spite of vitamin K1 therapy is an ominous sign. In a series of 23 patients with acute hepatic necrosis resulting in hepatic coma, every patient had a markedly increased prothrombin time (Fig 1) . The 3 survivors were among those with the shortest times: one of the fatal cases showed a value eight times that of the control prothrombin time (Cook & Sherlock 1965) . Such values in ajaundiced patient are contraindications to any surgery. The presence of spontaneous bruising with bleeding from the nose or mouth is even more serious. These abnormalities of the coagulation mechanism can be treated only by blood transfusion. Prothrombin, Factors VII, IX and X are well preserved in bank blood whereas Factor V and platelet deficiency is relieved only by fresh blood. In the last two years at the Royal Free Hospital 45 patients were admitted with bleeding cesophageal varices. The mean number of units (pints) of blood required for transfusion in the first 24 hours was 3-8 and the mean total during that hospital admission was 11 units; the clinician must be prepared for re-bleeding, for this was noted in 32 of the 45 patients. The overall mortality for this group was 44 %. The mortality was only 18% in those with the milder haemorrhages who required only 5 units of blood or less; the mortality after this did not increase with the amount of blood transfused, being 50-60% in patients receiving up to more than 20 units (Fig 2) . Three patients required more than 40 units and one of these survived after a record of 52 units of blood transfused. Of course such statistics take no account of other factors, particularly the extent of liver failure, which are the real determinants in survival after bleeding cesophageal varices (Sherlock 1963) . The transfusion of such large quantities raised the possibility of citrate intoxication; this would be expected to be more common in those with liver disease, for the liver metabolizes citrate. A citric acid tolerance test has even been used to assess liver function. Very high concentrations of serum citrate have been observed during multiple transfusions in liver disease or in those with mechanical obstruction to the hepatic circulation (Bunker et al. 1955) ; these have been sufficient to depress the ionized calcium values significantly. In general, however, it has been doubted whether citrate intoxication is a real clinical problem even in those with hepatic dysfunction (Howland et al. 1957) ; much depends on the speed of transfusion; when one unit is transfused in five minutes difficulties may occur.
Spontaneous fibrinolytic activity has been known for some time in patients with chronic liver disease. This has been shown particularly after portacaval anastomosis when an increased tendency to operative and post-operative bleedings has been related to active fibrinolysis (Grossi et al. 1962 ). The liver probably produces an inhibitor of fibrinolysin (von Kaulla 1964 , O'Connell et al. 1964 ). An excellent example of this is seen with hepatic transplantation (Starzl et al. 1963 ). For some time during the operation the patient is virtually without a liver while the donor (cadaver) liver is being inserted: the fibrinolysis time (euglobulin lysis time) falls dramatically. This time measures inhibition of the fibrinolysis, which is followed by a fall in fibrinogen. This reaction is controlled by fresh blood transfusion, fibrinogen infusions and by e-aminocaproic acid (EACA); then follows a period of increased blood coagulability. Starzl and his group (1964, personal communication) have performed 5 hepatic transplants in man using cadaver -donors: 4 recipients suffered from carcinoma of the liver and one, a child, from biliary atresia. One patient died during the operation from hemorrhage and showed very low fibrinogen levels; one patient died twentythree days later from disruption of the bile ducts, presumably part of a rejection reaction; 3 died of pulmonary emboli six, eight and twenty-two days post-operatively. The problem of blood coagulation is one of the deterrents from gaining more experience with hepatic transplantation in man.
